Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLP SARS-CoV-2 Vaccine Phase 1 (Turkey)
NCT04818281Phase 1Completed
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of COVIBEL in coronavirus disease 2019 (COVID-19). Started Mar 2021; status: completed.
02
Drugs
COVIBEL
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04818281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818281.